Tuesday, October 25, 2022

THE LANCET: Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

 

“Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals

in England, Northern Ireland, Scotland, and Wales”; found an increased risk of severe COVID-19 outcomes beginning 10 weeks after completing the primary vaccination schedule

No comments: